Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26321 http://scihub22266oqcxt.onion/10.1002/jmv.26321 32692406!7404432!32692406     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32692406&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       J+Med+Virol 2021 ; 93 (2): 726-732 Nephropedia Template TP {{tp|p=32692406|t=2021. HIV/SARS-CoV-2 coinfection: A global perspective |pdf=|usr=}}{{32692406}} gab.com Text HIV/SARS-CoV-2 coinfection: A global perspective JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32692406 #FOAvip Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world and has become a global pandemic. Several medical comorbidities have been identified as risk factors for coronavirus disease 2019 (COVID-19). However, it remains unclear whether people living with human immunodefeciency virus (PLWH) are at an increased risk of COVID-19 and severe disease manifestation, with controversial suggestion that HIV-infected individuals could be protected from severe COVID-19 by means of antiretroviral therapy or HIV-related immunosuppression. Several cases of coinfection with HIV and SARS-CoV-2 have been reported from different parts of the globe. This review seeks to provide a holistic overview of SARS-CoV-2 infection in PLWH. Twit Text FOAVip HIV/SARS-CoV-2 coinfection: A global perspective ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=32692406 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32692406 #FOAvip English Wikipedia <ref>{{Cite pmid|32692406}}</ref> HIV/SARS-CoV-2 coinfection: A global perspective #MMPMID32692406 Kanwugu ON; Adadi P J Med Virol 2021[Feb]; 93 (2): 726-732 PMID32692406show ga Since its first appearance in Wuhan, China, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread throughout the world and has become a global pandemic. Several medical comorbidities have been identified as risk factors for coronavirus disease 2019 (COVID-19). However, it remains unclear whether people living with human immunodefeciency virus (PLWH) are at an increased risk of COVID-19 and severe disease manifestation, with controversial suggestion that HIV-infected individuals could be protected from severe COVID-19 by means of antiretroviral therapy or HIV-related immunosuppression. Several cases of coinfection with HIV and SARS-CoV-2 have been reported from different parts of the globe. This review seeks to provide a holistic overview of SARS-CoV-2 infection in PLWH. |*Immunocompromised Host[MESH] |*Pandemics[MESH] |Adult[MESH] |Anti-HIV Agents/*therapeutic use[MESH] |Antiretroviral Therapy, Highly Active/statistics & numerical data[MESH] |CD4-Positive T-Lymphocytes/drug effects/immunology/virology[MESH] |COVID-19/*epidemiology/immunology/mortality/virology[MESH] |Coinfection[MESH] |Comorbidity[MESH] |Diabetes Mellitus/epidemiology/physiopathology[MESH] |Female[MESH] |HIV Infections/drug therapy/*epidemiology/mortality/virology[MESH] |HIV/drug effects/growth & development/pathogenicity[MESH] |Humans[MESH] |Hypertension/epidemiology/physiopathology[MESH] |Male[MESH] |Middle Aged[MESH] |SARS-CoV-2/immunology/*pathogenicity[MESH] |Survival Analysis[MESH]HIV/SARS-CoV-2 coinfection: A global perspective (epmc).pdf DeepDyve Pubget Overpricing